Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight
NCT01828554
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Neoplasms
Interventions
DRUG:
Xeloda
Sponsor
University of Wisconsin, Madison